Sources Sought Notice - Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to include reagents, molecular PCR instrument/equipment, consumables, maintenance support and instrument warranties at BAMC.
ID: 12272024Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
  1. 1
    Posted Dec 27, 2024, 12:00 AM UTC
  2. 2
    Updated Dec 27, 2024, 12:00 AM UTC
  3. 3
    Due Jan 20, 2025, 10:00 PM UTC
Description

The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to support molecular genetic and infectious disease testing at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of molecular PCR instruments, reagents, consumables, maintenance support, and instrument warranties, with a base performance period from October 1, 2025, to September 30, 2030. This initiative is critical for enhancing the laboratory's capabilities in conducting various genetic tests, including those for Celiac Disease, Alzheimer’s Disease, and a comprehensive Dermatomycosis Panel, which are essential for informed health assessments and treatment decisions. Interested parties are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil, by the specified deadlines, as this notice is solely for information and planning purposes and does not constitute a solicitation.

Point(s) of Contact
Medina L. Woodson
(210) 539-8525
(210) 221-3446
medina.l.woodson.civ@health.mil
Salameya Paulouskaya
(210) 539-8656
(210) 221-3446
salameya.paulouskaya2.civ@health.mil
Files
Title
Posted
Dec 27, 2024, 7:04 PM UTC
The document outlines various genetic and medical tests, specifically detailing their types and corresponding point values for evaluation. The tests listed include Celiac/HLA-DQ8-h, Alzheimer’s/APOE Direct, Haemochromatosis 4SNP+Direct, and a Dermatomycosis Panel, each assigned a value of 120 points. This structure indicates a standardized assessment metric for these tests within the context of federal and state health assessments or grants. The focus suggests an initiative to promote genetic testing as a means to better understand health conditions and inform treatment decisions. Overall, the document serves to facilitate understanding and comparison of these specific medical tests, which may relate to broader public health initiatives or research under government funding avenues.
Similar Opportunities
Genetic Testing Services for Tripler Army Medical Center, HI
Buyer not available
The Department of Defense, through the Medical Readiness Contracting Office - Pacific, is seeking qualified contractors to provide genetic testing services for the Tripler Army Medical Center in Hawaii. This procurement aims to establish a Blanket Purchase Agreement (BPA) for these services, which are critical for supporting the healthcare needs of military personnel and their families. The BPA will have a total not-to-exceed value of $500,000 and a performance period from September 8, 2025, to September 7, 2030, with quotes due by May 6, 2025, at 10:00 AM HST. Interested parties should contact Ms. Deborah Wada at deborah.n.wada.civ@health.mil or call 808-433-9520 for further details.
Cost Per Test (CPT): Blood Bank Reagent Testing Supplies for Transfusion Services
Buyer not available
The Department of Defense, specifically the Department of the Army, is soliciting proposals for the provision of Blood Bank Reagent Testing Supplies for the Bayne Jones Army Community Hospital located in Fort Johnson, Louisiana. The procurement aims to secure comprehensive support, including the delivery of standardized testing supplies, maintenance of an integrated automated blood bank analyzer system, and adherence to regulatory compliance, particularly FDA standards. These supplies and services are critical for ensuring the operational efficiency and safety of transfusion services within the hospital. Interested vendors should contact Kevin Vijayan at kevin.vijayan.civ@health.mil or 210-538-4861, or Albert Lee at albert.a.lee.civ@health.mil for further details regarding the solicitation, which is expected to cover the contract period from 2025 to 2030.
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
Microbial Testing Supplies - Bridge Contract
Buyer not available
The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
Q301--|554 | New Base +4 RTPCR GI & Respiratory Testing
Buyer not available
The Department of Veterans Affairs, through the Network Contracting Office 19, is conducting a Sources Sought Notice to identify potential vendors for Real-Time Polymerase Chain Reaction (RT-PCR) GI and Respiratory Testing services to support the Rocky Mountain Regional VA Medical Center in Aurora, Colorado. The procurement aims to secure comprehensive equipment, reagents, supplies, and services necessary for effective laboratory testing operations, which are critical for accurate diagnosis and public health management, particularly in identifying infectious diseases. Interested parties are encouraged to submit their capabilities, including business size and proposed solutions, by May 12, 2025, to the designated Contracting Officer, Alejandra Sierra, at Alejandra.Sierra@va.gov. This initiative may lead to a single contract award, potentially set aside for small businesses, depending on the responses received.
Notice of Intent to Sole Source Cost Per Reportable Testing and Lease of MicroScan WalkAway for Naval Medical Center Portsmouth
Buyer not available
The Department of Defense, through the Defense Health Agency, intends to award a sole source Firm-Fixed-Price contract to Beckman Coulter, INC. for the provision of a Cost Per Reportable MicroScan WalkAway system, which includes equipment lease, consumables, and maintenance support. This procurement is critical as the MicroScan WalkAway system is already validated and in use at the Naval Medical Center Portsmouth, ensuring continuity in laboratory operations and avoiding substantial duplication of costs estimated at approximately $300,000 if a new vendor were to be selected. The total estimated value of the contract is $550,348, with a performance period starting from June 1, 2025, to May 31, 2026, and the Government is seeking responses that demonstrate the advantages of competition. Interested parties can direct inquiries to Contract Specialist Lisa Wilk at lisa.c.wilk.civ@health.mil, and should reference "Notice of Intent Question Submission 12215615" in their correspondence.
6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
Buyer not available
The Department of Veterans Affairs intends to award a sole-source contract to Cepheid for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to meet the government's requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time. Interested parties should submit their technical packages to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov, noting that the government will not compensate for the information provided.
Chemistry Testing - Cost Per Reportable Result
Buyer not available
The Department of Defense, specifically the U.S. Army Health Clinic in Vicenza, Italy, is seeking proposals for the provision of an automated chemistry analyzer and associated reagents under a Cost Per Reportable Result (CPRR) model. The contractor will be responsible for delivering a fully automated analyzer capable of conducting various chemistry and immunology tests, along with all necessary consumables and maintenance, to support the laboratory mission at the clinic. This procurement is critical for enhancing medical readiness and ensuring efficient laboratory services for the Army, with a contract period anticipated from July 1, 2025, to June 30, 2030. Interested parties should direct inquiries to Elena Raspitha at elena.m.raspitha.civ@health.mil, with questions due by May 8, 2025, at 17:00 Central European Time.
Urinalysis Reagents and Consumables w/Leased Analyzer for Fort Sill, OKklahoma
Buyer not available
The Department of Defense is preparing to issue a solicitation for a firm fixed-price contract to supply Urinalysis Reagents and Consumables, along with a leased analyzer, for the Reynolds Army Health Clinic located in Fort Sill, Oklahoma. This procurement is structured on a cost per reportable result basis, emphasizing the importance of timely and adequate delivery of supplies to meet the healthcare needs of the clinic. The goods and services sought are critical for conducting urinalysis, which plays a vital role in patient diagnostics and healthcare management. Interested vendors should note that the solicitation is anticipated to be released around April 28, 2025, and can contact MEDCOM at karan.e.quiles.civ@health.mil or by phone at 254-288-8000 for further information.
Transfusion Services
Buyer not available
The Department of Defense, through the Medical Regional Contracting Office-West (MRCO-W), is seeking potential sources for a software solution to manage tracking and tracing of biologic and non-biologic implants at Brooke Army Medical Center. The procurement requires licenses for 70 individual users to access the Tracs4Life system, with a performance period from September 1, 2025, to August 31, 2026, and four optional renewal years. This software is crucial for maintaining compliance with regulatory standards set by organizations such as TJC, CAP, AABB, and the FDA for tissue specimen management. Interested parties must submit their responses, including company identification and a ten-page capability statement, by 4:00 PM CST on May 1, 2025, to Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.